Need Access?
If you are a licensed provider and would like to access the Practitioner List, or your payment statements please e-mail nlpdp@bell.ca to request a USERNAME and PASSWORD.

 
Document Name: Bulletin #: Date Range: To


Document NameBulletin NumberDateView
Update to Bulletin No. 60: Pharmaceutical Services Fax Line 709-729-2851652025-May-09Word PDF
Short-Stock: Olopatadine 0.2 percent Per Ml642025-May-09Word PDF
Update - Short-Stock: Oxycodone Hydrochloride 20mg632025-May-09Word PDF
Short-Stock: Tolterodine Extended Release 4mg622025-May-08Word PDF
Benefit List Update: New Addition: Tyenne612025-May-08Word PDF
Revision to Bulletin 59: Pharmaceutical Services602025-May-06Word PDF
Fax Line at Pharmaceutical Services592025-May-06Word PDF
Update: Short-Stock: Ipratropium Bromide 20mcg/Metered Dose Inhaler582025-May-02Word PDF
Update - Pharmaceutical Services Moving Locations572025-May-01Word PDF
Delisting from NIDPF and NLPDP: Proctosedyl Ointment category effective May 1, 2025562025-Apr-30Word PDF
Online version of NIDPF Vol. 92 effective May 1, 2025552025-Apr-30Word PDF
Pharmaceutical Services Moving Locations542025-Apr-30Word PDF
Short-Stock: Ipratropium Bromide 20mcg/Metered Dose Inhaler532025-Apr-29Word PDF
Benefit Status Effective May 1, 2025522025-Apr-28Word PDF
NIDPF Vol. 92 Supplement Effective May 1, 2025 - Refer to Bulletin #52 for Benefit Status512025-Apr-28Word PDF
Update: Short-Stock: Testosterone 100mg/ml502025-Apr-25Word PDF
Update: Short-Stock: Ipratropium Bromide 20mcg/Metered Dose Inhaler492025-Apr-25Word PDF
Short-Stock: Oxycodone Hydrochloride 20mg482025-Apr-24Word PDF
Update - Short-Stock: Olmesartan/Hydrochlorothiazide 40mg/25mg472025-Apr-22Word PDF
Benefit List Update: New Addition of Testosterone Enanthate 200mg/ml Injection462025-Apr-17Word PDF
Page  Go
Page 1 of 52
Document Name: Date Range: To


Document NameDateView
Coverage Status Table - April 20252025-Apr-15 PDF
Coverage Status Table - March 20252025-Mar-21 PDF
Coverage Status Table - February 20252025-Feb-18 PDF
Coverage Status Table - January 20252025-Jan-15 PDF
Coverage Status Table - December 20242024-Dec-06 PDF
Coverage Status Table - November 20242024-Nov-14 PDF
Coverage Status Table - October 20242024-Oct-16 PDF
Coverage Status Table - September 20242024-Sep-23 PDF
Coverage Status Table - August 20242024-Aug-16 PDF
Coverage Status Table - July 20242024-Jul-04 PDF
Coverage Status Table - June 20242024-Jun-18 PDF
Coverage Status Table - May 20242024-May-15 PDF
Coverage Status Table - April 20242024-Apr-23 PDF
Coverage Status Table - March 20242024-Mar-12 PDF
Coverage Status Table - February 20242024-Feb-21 PDF
Coverage Status Table - January 20242024-Jan-24 PDF
Coverage Status Table - December 20232023-Dec-12 PDF
Coverage Status Table - November 20232023-Nov-20 PDF
Coverage Status Table - October 20232023-Oct-25 PDF
Coverage Status Table - September 20232023-Sep-08 PDF
Page  Go
Page 1 of 2
Document Name: Date Range: To


Document NameDateView
Diabetic Listing - December 13, 20222025-Mar-12Word 
 
Page 1 of 1
Document Name: Bulletin #: Date Range: To


Document NameBulletin NumberDateView
Benefit List Update: New Addition: Tyenne612025-May-08Word PDF
Benefit List Update: New Addition of Testosterone Enanthate 200mg/ml Injection462025-Apr-17Word PDF
Benefit List Update: New Addition: Remsima 120 mg/ml.452025-Apr-15Word PDF
New addition: EYLEA HD 8 MG/0.07 ML Pre-filled syringe442025-Apr-15Word PDF
Benefit list updates_New addition_AKEEGA 412025-Mar-31Word PDF
Benefit List Update: New addition: IXIFI 100mg Vial402025-Mar-31Word PDF
Benefit List Update: New addition: REMDANTRY 100mg Vial392025-Mar-31Word PDF
Benefit List Update: New Addition Special Authorization: OMVOH372025-Mar-24Word PDF
Benefit List Update: QULIPTA 10mg, 30mg, 60mg tablet222025-Feb-24Word PDF
Benefit List Update: New Addition: Vraylar 152025-Feb-12Word PDF
Benefit List Update: New Addition: Eylea HD142025-Feb-11Word PDF
Benefit List Update: STEQEYMA 62025-Jan-21Word PDF
Benefit list updates_New addition_WELIREG42025-Jan-15Word PDF
Benefit List Update: Livtencity22025-Jan-13Word PDF
Benefit List Update: Open Benefit2002024-Dec-13Word PDF
Benefit List Update_New Criteria_Trikafta1982024-Dec-12Word PDF
Benefit List Update_New Criteria_INLYTA Tablets1972024-Dec-11Word PDF
Benefit List Update: New addition: CoSentyx 75mg1952024-Dec-05Word PDF
Benefit List Update: New addition: RYMTI 50 MG/ML1932024-Dec-03Word PDF
Benefit List Update: Rinvoq for ankylosing Spondylitis1832024-Nov-12Word PDF
Page  Go
Page 1 of 7
Document Name: Bulletin #: Date Range: To


Document NameBulletin NumberDateView
Short-Stock: Olopatadine 0.2 percent Per Ml642025-May-09Word PDF
Update - Short-Stock: Oxycodone Hydrochloride 20mg632025-May-09Word PDF
Short-Stock: Tolterodine Extended Release 4mg622025-May-08Word PDF
Update: Short-Stock: Ipratropium Bromide 20mcg/Metered Dose Inhaler582025-May-02Word PDF
Short-Stock: Ipratropium Bromide 20mcg/Metered Dose Inhaler532025-Apr-29Word PDF
Update: Short-Stock: Testosterone 100mg/ml502025-Apr-25Word PDF
Update: Short-Stock: Ipratropium Bromide 20mcg/Metered Dose Inhaler492025-Apr-25Word PDF
Short-Stock: Oxycodone Hydrochloride 20mg482025-Apr-24Word PDF
Update - Short-Stock: Olmesartan/Hydrochlorothiazide 40mg/25mg472025-Apr-22Word PDF
Update - Short-Stock: Budesonide 0.25mg/ml432025-Apr-04Word PDF
Short-Stock: Budesonide 0.125mg/ml352025-Mar-21Word PDF
Update - Short-Stock: Octreotide 20mg/Vial322025-Mar-21Word PDF
Update - Short-Stock: Estradiol Transdermal 50 ug Patch312025-Mar-21Word PDF
Update - Short-Stock: Estradiol Transdermal 75ug302025-Mar-21Word PDF
Short-Stock: Olmesartan/Hydrochlorothiazide 40mg/25mg292025-Mar-19Word PDF
Short-Stock: Ipratropium Bromide 20mcg/Metered Dose Inhaler272025-Mar-10Word PDF
Short-Stock: Octreotide 20mg/Vial262025-Mar-05Word PDF
Update - Short-Stock: Betahistine Dihydrochloride 24mg252025-Mar-04Word PDF
Short-Stock - Testosterone 100mg/ml232025-Feb-27Word PDF
Short Stock - Estradiol Transdermal 50 ug Patch212025-Feb-20Word PDF
Page  Go
Page 1 of 8
Document Name: Bulletin #: Date Range: To


Document NameBulletin NumberDateView
Delisting from NIDPF and NLPDP: Proctosedyl Ointment category effective May 1, 2025562025-Apr-30Word PDF
Online version of NIDPF Vol. 92 effective May 1, 2025552025-Apr-30Word PDF
Benefit Status Effective May 1, 2025522025-Apr-28Word PDF
NIDPF Vol. 92 Supplement Effective May 1, 2025 - Refer to Bulletin #52 for Benefit Status512025-Apr-28Word PDF
Online version of NIDPF Vol. 92 effective April 1, 2025422025-Apr-01Word PDF
Benefit Status Effective April 1, 2025342025-Mar-21Word PDF
NIDPF Vol. 92 Supplement Effective April 1, 2025 - Refer to Bulletin #34 for Benefit Status332025-Mar-21Word PDF
Online version of NIDPF Vol. 91 effective March 1, 2025242025-Feb-28Word PDF
Benefit Status Effective March 1, 2025202025-Feb-20Word PDF
NIDPF Vol. 91 Supplement Effective March 1, 2025 - Refer to Bulletin #20 for Benefit Status192025-Feb-20Word PDF
Online version of NIDPF Vol. 91 effective February 1, 2025102025-Jan-31Word PDF
Benefit Status Effective February 1, 202582025-Jan-27Word PDF
NIDPF Vol. 91 Supplement Effective February 1, 2025 - Refer to Bulletin #8 for Benefit Status72025-Jan-27Word PDF
NIDPF Update: Delisting of Lanthanum 500mg, 750mg, and 1000mg Tablets12025-Jan-13Word PDF
Online version of NIDPF Vol. 91 effective January 1, 20252102024-Dec-31Word PDF
Benefit Status Effective January 1, 20252052024-Dec-19Word PDF
NIDPF Vol. 91 Supplement Effective January 1, 2025 - Refer to Bulletin #205 for Benefit Status2042024-Dec-19Word PDF
NIDPF Update - Delisting of Alitretinoin 10mg and Alitretinoin 30mg1962024-Dec-06Word PDF
Online version of NIDPF Vol. 91 effective December 1, 20241902024-Nov-29Word PDF
Benefit Status Effective December 1, 20241892024-Nov-21Word PDF
Page  Go
Page 1 of 5
Document Name: Date Range: To


Document NameDateView
2025 - Payment Schedule2024-Dec-03Word PDF
2024 - Payment Schedule2023-Dec-05Word PDF
 
Page 1 of 1